Clinical Trial Update: Alpha Omega Trial: Study of Omega-3 Fatty Acids and Coronary Mortality [NA]

View source ↗

Summary

The Alpha Omega Trial, evaluating omega-3 fatty acids for reducing coronary mortality in cardiovascular disease, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Wageningen University | Conditions: Cardiovascular Diseases | NA | Status: COMPLETED